Crohn Disease: all 1,923 studies

Page 6 of 20. Open to participants first (467), then studies with results posted, then the rest; newest registration first within each.

• A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's DiseaseTerminatedNCT04173273Phase 2/3Results posted
• A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)CompletedNCT04163016Phase 1Results posted
• A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal FistulaTerminatedNCT04118088Phase 4Results posted
• A Study Evaluating Participants With Moderately to Severely Active Crohn's DiseaseTerminatedNCT04102111Phase 2Results posted
• Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal FistulaCompletedNCT04075825Phase 3Results posted
• A Dietary Intervention Study on the Microbiome in Crohn's Disease PatientsCompletedNCT04065048Not applicableResults posted
• ENhanced Recovery in CHildren Undergoing SurgeryCompletedNCT04060303Phase 3Results posted
• Perianal Fistula (PAF) Validation and Burden of Illness StudyCompletedNCT03981939Results posted
• Open-label Extension Study of Brazikumab in Crohn's DiseaseTerminatedNCT03961815Phase 3Results posted
• CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)CompletedNCT03945019Phase 3Results posted
• A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After SurgeryTerminatedNCT03943446Phase 2Results posted
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's DiseaseCompletedNCT03926130Phase 3Results posted
• Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)CompletedNCT03884439Results posted
• Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's DiseaseTerminatedNCT03870334Phase 2Results posted
• Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active InflammationTerminatedNCT03850509Phase 2Results posted
• Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel DiseaseCompletedNCT03836612Results posted
• The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort StudyCompletedNCT03835780Results posted
• ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDICompletedNCT03829475Phase 2Results posted
• MRE as a Screening Tool for axSpA in IBDCompletedNCT03817983Results posted
• Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel DiseaseCompletedNCT03801928Results posted
• Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With VedolizumabCompletedNCT03798691Phase 4Results posted
• A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's DiseaseCompletedNCT03782376Phase 3Results posted
• An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's DiseaseTerminatedNCT03759288Phase 2/3Results posted
• A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's DiseaseCompletedNCT03752970Phase 2Results posted
• A Study of E6011 in Participants With Active Crohn's DiseaseCompletedNCT03733314Phase 2Results posted
• Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)CompletedNCT03723447Phase 4Results posted
• A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) ParticipantsCompletedNCT03710486Results posted
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's DiseaseTerminatedNCT03650413Phase 2Results posted
• Efficacy and Safety of TD-1473 in Crohn's DiseaseTerminatedNCT03635112Phase 2Results posted
• Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)TerminatedNCT03627091Phase 3Results posted
• An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's DiseaseTerminatedNCT03599622Phase 2Results posted
• Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)TerminatedNCT03566823Phase 3Results posted
• Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)TerminatedNCT03559517Phase 3Results posted
• A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life PracticeCompletedNCT03532932Results posted
• Autoimmune Protocol Diet and Inflammatory Bowel DiseaseCompletedNCT03512327Not applicableResults posted
• A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD)CompletedNCT03488030Results posted
• A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's DiseaseTerminatedNCT03478956Phase 1Results posted
• Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's DiseaseCompletedNCT03476317Phase 2Results posted
• An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's DiseaseTerminatedNCT03467958Phase 3Results posted
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's DiseaseActive, not recruitingNCT03466411Phase 2/3Results posted
• Safety and Efficacy of Adalimumab Versus Ustekinumab for One YearCompletedNCT03464136Phase 3Results posted
• A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's DiseaseTerminatedNCT03464097Phase 3Results posted
• Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's DiseaseCompletedNCT03440385Phase 3Results posted
• Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's DiseaseTerminatedNCT03440372Phase 3Results posted
• Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel DiseaseCompletedNCT03397108Results posted
• Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's DiseaseCompletedNCT03395184Phase 2Results posted
• Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's DiseaseCompletedNCT03357471Phase 3Results posted
• A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic TherapiesCompletedNCT03345849Phase 3Results posted
• A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic TherapyCompletedNCT03345836Phase 3Results posted
• A Trial of Yoga in Pediatric Inflammatory Bowel DiseaseCompletedNCT03338894Not applicableResults posted
• A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese ParticipantsCompletedNCT03329209Phase 1Results posted
• A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)CompletedNCT03283085Phase 3Results posted
• Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)CompletedNCT03279081Phase 3Results posted
• Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease.CompletedNCT03241368Not applicableResults posted
• Ultrasound Evaluation of Crohn's DiseaseTerminatedNCT03235180Phase 4Results posted
• Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.CompletedNCT03234907Phase 3Results posted
• Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)CompletedNCT03196427Phase 2Results posted
• Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative ColitisTerminatedNCT03169894Phase 1Results posted
• Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal PainCompletedNCT03155945Phase 2Results posted
• Defining Predictors of RT Response to Vedolizumab in IBDCompletedNCT03142321Phase 4Results posted
• Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)CompletedNCT03138655Phase 2Results posted
• Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With UstekinumabCompletedNCT03107793Phase 3Results posted
• A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's DiseaseCompletedNCT03105128Phase 3Results posted
• A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic TreatmentCompletedNCT03104413Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's DiseaseCompletedNCT03077412Phase 2Results posted
• Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's DiseaseCompletedNCT03058679Not applicableResults posted
• Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)CompletedNCT03046056Phase 2Results posted
• Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's DiseaseCompletedNCT03009396Phase 3Results posted
• A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's DiseaseCompletedNCT02976129Phase 2Results posted
• National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real LifeCompletedNCT02925338Results posted
• Filgotinib in Long-Term Extension Study of Adults With Crohn's DiseaseTerminatedNCT02914600Phase 3Results posted
• Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's DiseaseCompletedNCT02914561Phase 3Results posted
• A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's DiseaseCompletedNCT02891226Phase 2Results posted
• A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative ColitisCompletedNCT02883452Phase 1Results posted
• Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's DiseaseCompletedNCT02877134Phase 2Results posted
• BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and ImmunogenicityCompletedNCT02871635Phase 3Results posted
• A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's DiseaseCompletedNCT02782663Phase 2Results posted
• Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) TherapyCompletedNCT02772965Phase 3Results posted
• Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's DiseaseCompletedNCT02765256Phase 2Results posted
• Triple Combination Therapy in High Risk Crohn's Disease (CD)CompletedNCT02764762Phase 4Results posted
• Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)CompletedNCT02750800Results posted
• Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's DiseaseTerminatedNCT02743806Phase 4Results posted
• Imaging Biomarkers in Crohn's Associated SpondyloarthritisCompletedNCT02709694Results posted
• Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBDCompletedNCT02680756Phase 3Results posted
• A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's DiseaseTerminatedNCT02641392Phase 3Results posted
• Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's DiseaseCompletedNCT02630966Phase 4Results posted
• A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's DiseaseCompletedNCT02620046Phase 3Results posted
• Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)CompletedNCT02611817Phase 3Results posted
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's DiseaseTerminatedNCT02596893Phase 3Results posted
• Post-Marketing Surveillance of Humira in Korean Pediatric Crohn's Disease (CD) Patients Under the "New-Drug Re-examination"CompletedNCT02578238Results posted
• Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's DiseaseTerminatedNCT02574637Phase 2Results posted
• Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's DiseaseCompletedNCT02559713Phase 4Results posted
• Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel DiseaseCompletedNCT02539368Results posted
• A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block TechniquesCompletedNCT02538679Not applicableResults posted
• The Effect of Riboflavin in Crohn's DiseaseCompletedNCT02538354Not applicableResults posted
• Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)CompletedNCT02538341Phase 2Results posted
• Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's DiseaseCompletedNCT02531113Phase 2Results posted
• A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's DiseaseCompletedNCT02513459Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's DiseaseCompletedNCT02499783Phase 3Results posted
• The Use of Small Bowel Ultrasound to Predict Response to Remicade InductionCompletedNCT02488005Not applicableResults posted

← Crohn Disease overview